Method and apparatus for the detection and occlusion of blood vessels

A non-invasive blood vessel occlusion device includes a pair of pressure-applying members with opposed tissue-contacting surfaces, a supporting shaft configured to adjust the distance between tissue-contacting surfaces, and at least one sensor for locating a blood vessel disposed on at least one pressure-applying member. Blood vessels may be occluded by indirectly compressing the artery by compressing tissue near to an artery. The occlusion device finds use in, for example, treating uterine disorders and conditions which may be treated by occlusion of the uterine arteries. A uterine artery may be accessed via a body cavity, such as a patient's vagina, and may be occluded by compressing a portion of the vaginal wall around a portion of a uterine artery.

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation-in-part of U.S. patent application Ser. No. 10/113,096, entitled “Method and Apparatus for the Detection and Ligation of Uterine Arteries” filed Mar. 28, 2002, which is now U.S. Pat. No. 7,229,465, which claims priority from U.S. Provisional Application 60/279,477 filed Mar. 28, 2001; and this application is a continuation-in-part of U.S. patent application Ser. No. 09/908,815, filed Jul. 20, 2001, which is now U.S. Pat. No. 7,223,279, which is a continuation-in-part of U.S. patent application Ser. No. 09/556,934, filed Apr. 21, 2000, which is now U.S. Pat. No. 6,550,482, all of which applications are hereby incorporated by reference in their entirety and from which priority is hereby claimed under 35 U.S.C. §119(e) and 35 U.S.C. §120.

FIELD OF THE INVENTION

The invention relates generally to the field of treatment of diseases and conditions by the regulation of blood flow in blood vessels. In particular, the invention is directed to the treatment of uterine conditions by detecting and regulating blood flow thereto.

BACKGROUND OF THE INVENTION

Hysterectomy (surgical removal of the uterus) is performed on approximately 600,000 women annually in the United States. Hysterectomy is often the therapeutic choice for the treatment of uterine cancer, adenomyosis, menorrhagia, prolapse, dysfunctional uterine bleeding (abnormal menstrual bleeding that has no discrete anatomic explanation such as a tumor or growth), and muscular tumors of the uterus, known as leimyoma or uterine fibroids.

However, hysterectomy is a drastic treatment, having many undesirable characteristics. Thus, any method which can approximate the therapeutic result of a hysterectomy without removing the uterus would be a significant improvement in this field. Newer treatment methods have been developed for some diseases which may spare these women a hysterectomy.

In 1995, it was demonstrated that uterine fibroids could be treated without hysterectomy using a non-surgical therapy, specifically comprising bilateral intraluminal occlusion of the uterine arteries (Ravina et al., “Arterial Embolization to Treat Uterine Myomata”, Lancet Sep. 9, 1995; Vol. 346; pp. 671-672, incorporated in its entirety herein). This technique is known as “uterine artery embolization”. In this technique, uterine arteries are accessed via a transvascular route from a common femoral artery into the left and right uterine arteries.

The uterus has a dual (or redundant) blood supply, the primary blood supply being from the bilateral uterine arteries, and the secondary blood supply from the bilateral ovarian arteries. Consequently, when both uterine arteries are occluded, i.e. bilateral vessel occlusion, the uterus and the fibroids contained within the uterus are both deprived of their blood supply. However, as demonstrated by Ravina et al., the effect on the fibroid is greater than the effect on the uterus. In most instances, the fibroid withers and ceases to cause clinical symptoms.

However, many physicians do not possess the skill or equipment necessary to perform catheter-based uterine artery embolization under radiologic direction. Accordingly, only thousands of uterine artery embolizations have been performed, worldwide, over the past three years, whereas hundreds of thousands of hysterectomies have been performed each year for uterine fibroids which are symptomatic.

What is needed, therefore, are devices and methods to detect blood vessels and blood flow in blood vessels, and devices and methods to occlude blood flow in blood vessels such as the uterine arteries that can be used by physicians of ordinary skill in a simple medical setting or environment.

SUMMARY OF THE INVENTION

The invention is directed to non-invasive devices, systems and methods for extravascularly detecting blood flow in a blood vessel, and for occluding an a blood vessel effective to reduce or abolish blood flow in it. The non-invasive devices, systems and methods embodying features of the invention are configured to be non-surgically applied externally of a blood vessel which they occlude, and are preferably applied at least in part extracorporeally. The occlusion is temporary, and may be partial or complete. One method of occluding a blood vessel comprises clamping the blood vessel effective to compress it so that blood flow through the vessel is reduced, or is abolished. Such clamping of a blood vessel may be direct or may be indirect. Preferably, clamping of a blood vessel effective to compress it is accomplished by applying a non-invasive blood vessel occlusion device to tissue near to a blood vessel (e.g., onto tissue surrounding the vessel). A blood vessel occlusion device may also be applied directly onto a blood vessel effective to compress the blood vessel.

In one embodiment of the invention, a non-invasive blood vessel occluding device (such as a clamp with a sensor) may be applied to a portion of a vaginal wall to detect and/or locate, and to occlude the uterine arteries. A vaginal clamp embodying features of the invention may used to sense the location of a uterine artery adjacent a vaginal wall, and may be used to compress and occlude a uterine artery adjacent a vaginal wall. The vaginal wall may be distended by an occlusion device so as to more closely approach a uterine artery; such an approach may aided by applying pressure or force to the uterus (e.g., by pulling on the uterine cervix). A uterine cervix may be grasped or pulled by any suitable device or implement, including forceps, suction devices, and other instruments, such as a tenaculum.

A non-invasive blood vessel occluding device embodying features of the invention may be a non-invasive intravaginal uterine artery occlusion device, comprising a pair of pressure-applying members having opposed tissue-contacting surfaces on distal portions thereof; at least one supporting shaft extending from a proximal extremity of at least one of the pressure-applying members which is configured to adjust the distance between the opposed tissue-contacting surfaces of the pressure-applying members; and at least one blood flow sensing sensor on one of the opposed tissue-contacting surfaces. Alternatively, at least one sensor for locating a blood vessel disposed on at least one pressure-applying member. An embodiment of a non-invasive blood vessel occlusion device embodying features of the invention may have, for example, a handle, a clamping member configured to apply pressure or force to body tissue, and a sensor for locating a blood vessel.

A pressure-applying member, such as a clamping member, may be, e.g., a jaw or jaws configured to engage a blood vessel or to engage tissue adjacent a blood vessel. A supporting shaft, such as a handle, is preferably configured for manipulating the jaw or jaws. In some embodiments of devices having features of the invention, a pressure-applying member may be attached to a connecting portion that is configured so that a jaw may be placed within a vagina while a handle remains outside a patient's body and available for use by an operator.

A sensor for locating a blood vessel may sense sound, pulsation, blood flow or other indicator related to a blood vessel. Thus, a sensor for locating a blood vessel may be a blood flow sensor, a sound sensor, a pressure sensor, a strain sensor, a stress sensor, a chemical sensor, an electromagnetic radiation sensor, or other sensor, and may be a combination of such sensors. A sound sensor may be an ultrasound sensor, including a Doppler ultrasound sensor. The sensor for locating a blood vessel, including a sensor for measuring blood flow, is preferably disposed in or on a pressure-applying member, and is preferably mounted to the face of a tissue-contacting surface, such as the face of a jaw of a clamp. A sensor is preferably oriented perpendicularly to the clamp face, although in embodiments of devices having features of the invention a sensor may assume other orientations.

A system embodying features of the invention may include an blood vessel occluding device having a pair of pressure-applying members configured to apply pressure or force to body tissue, at least one supporting shaft, a sensor for locating a blood vessel, and a sensor controller which may include an energy source. A system may further include a device for grasping a portion of a patient's body, such as a device for grasping a uterine cervix.

A sensor controller may be configured to aid in detecting a location of a blood vessel, by, e.g., providing a signal related to the output of a sensor that may be readily used by an operator. A sensor controller may include an energy source configured to provide energy for operating a sensor for sensing a location of a blood vessel, such as ultrasound energy, electrical energy, or electromagnetic energy. The energy may be directly provided by the energy source or may be provided by the sensor with the aid of the energy source. Ultrasound energy useful for sensing a location of a blood vessel or of blood flow in a blood vessel may have a frequency of less than about 20 MegaHertz (MHz), such as between about 5 MHz and about 19 MHz, preferably between about 6 MHz and about 10 MHz, more preferably a frequency of about 8 MHz. Electromagnetic energy useful for sensing a location of a blood vessel or of blood flow in a blood vessel may have a wavelength of between about 500 nanometers (nm) and about 2000 nm, preferably between about 700 nm and about 1000 nm.

A method for occluding a blood vessel may include locating a blood vessel with a sensor and compressing a portion of the blood vessel with a non-invasive blood vessel occluding device which includes the sensor. A method of occluding a uterine artery of a patient may include locating a uterine artery with a sensor and compressing a portion of the uterine artery with a non-invasive blood vessel occluding device which includes the sensor. Compressing a portion of a uterine artery may include applying pressure or force to a vaginal wall. In addition, methods for occluding a uterine artery include applying tension to a uterus and applying pressure or force to a vaginal wall, and include engaging a uterine cervix with a grasping implement (e.g., by pulling on the uterine cervix) while applying force or pressure to a vaginal wall to occlude a uterine artery.

The non-invasive devices, systems and methods embodying features of the invention allow the non-surgical location and occlusion of blood vessels, providing therapeutic temporary, partial or complete, reduction or abolition of blood flow in the located and occluded blood vessels. Use of the devices, systems and methods of the present invention thus allow the occlusion of a blood vessel without the puncture of bodily tissue, and without the need for radiographic equipment or for skill in the use of radiographic techniques. The devices and methods are simpler and more readily used and removed than other methods and devices, and provide improved treatments for serious conditions and diseases, including uterine fibroids, dysfunctional uterine bleeding (DUB), adenomyosis, post-partum hemorrhage, and other uterine disorders. The devices, systems and methods embodying features of the invention thus provide tools and methods for effective treatment of diseases and conditions that otherwise require invasive and irreversible treatments such as removal of a uterus.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a plan view of a system embodying features of the invention including a vaginal clamp embodying features of the invention disposed in an open configuration.

FIG. 2 is a fragmentary sectional view of a distal portion of a clamping device embodying features of the invention in a closed configuration.

FIG. 3 is a perspective view of a jaw portion of a vaginal clamp embodying features of the invention disposed in an open configuration.

FIG. 4 is a transverse cross-sectional view of a jaw portion of the clamping device of FIG. 3 taken at line 4-4.

FIG. 5 is schematic diagram of a reproductive system of a human female including major blood vessels providing blood flow to the uterus.

FIG. 6 is a schematic diagram illustrating the use of a vaginal clamp embodying features of the invention in the occlusion a uterine artery of a female human patient.

 DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

FIGS. 1-4 show a non-invasive blood vessel-occluding system 10 embodying features of the invention. The system 10 includes a clamping component 12, including handles 14, having finger holes 16, and pressure-applying members 18 with jaws 20 on their distal ends. Jaws 20 have serrated tissue-contacting surfaces 22 configured to engage and hold onto tissue when jaws 20 are pressed into a patient's body tissue. Pressure-applying members 18 are pivotally connected with each other at pivot point 24; handles 14 (which act as supporting shafts for device 12) are also integral with the pressure-applying members 18 and are pivotally connected with each other at pivot point 24. Squeezing handles 14 together, preferably by fingers of an operator's hand engaged with finger holes 16, is effective to cause tissue-contacting surfaces 22 to approach one another as pressure-applying members 18. Such motion may provide mechanical advantage where the lengths of pressure-applying members 18 are not equal to the lengths of handles 14, allowing for greater or lesser force or pressure at tissue-contacting surfaces 22 than is applied at finger holes 16. For example, where the lengths of pressure-applying members 18 are less than the lengths of handles 14, greater force may be applied at tissue-contacting surfaces 22 than is applied at finger holes 16. Releasable ratcheting mechanism 26 includes two complementary portions configured to engage with each other and to lock handles 14 in a closed position, maintaining pressure or force between tissue-contacting surfaces 22 while the locking mechanism 26 is engaged.

A non-invasive blood vessel-occluding system 10 also includes a sensor component 28, such as a blood flow detection system, which includes a sensor 30 and a cable 32 having a proximal connector 34 configured to operably engage with a sensor control device 36. A connector 34 is preferably a releasable connector configured to readily engage and disengage with a sensor control device 36. Alternatively, a cable 32 may directly and permanently engage a sensor control device 36 without having a connector 34. A sensor control device 36 may be configured to supply power that may be required by a sensor 30, to receive signals from a sensor 30, and to carry sensor signal outputs to a sensor controller for interpretation by an operator. A sensor 30 may be a passive sensor (e.g., configured to detect intrinsic signals indicating the presence of a blood vessel) or active (e.g., configured to emit a signal, and to detect a signal in response to, or derived from, the emitted signal). An emitted signal may be pulsed or continuous. A sensor controller 36 may produce and provide signals or signal energy used for sensing (e.g., ultrasound or infra-red signals or energy) or may provide energy to a sensor 30 to aid the sensor 30 to produce or provide signals or signal energy. Cable 32 may include an electrical cable, an optical fiber, a waveguide, other conduit for carrying energy or signals, or a combination of these.

A sensor 30 may be a blood flow sensor configured to identify and locate a blood vessel and for determining the degree of occlusion of the blood vessel. In particular, a sensor 30 may be configured to indicate the location of a blood vessel with respect to a jaw 20 of a device embodying features of the invention. A sensor 30 may thus be a blood flow sensor, but may also be a microphone (e.g., to sense heart sounds or other sounds not directly “blood flow” sounds, although turbulence due to flow may also produce detectable sounds), a pressure transducer or stress or strain gauge to detect pulsations in an artery due to heart action, a pH sensor, an electromagnetic radiation sensor, such as an infrared sensor, to detect a blood vessel (e.g., to detect hemoglobin), or other sensor. Preferably, sensor 30 is a Doppler ultrasound sensor, configured to emit and to detect ultrasound effective to detect blood flow and to locate a blood vessel.

FIG. 2 illustrates a distal part of a system 10 embodying features of the invention, showing portions of pressure-applying members 18, and jaws 20 having tissue-contacting surfaces 22. In the embodiment shown in this figure, jaws 20 meet pressure-applying members 18 at an angle, unlike the embodiment shown in FIG. 1 where jaws 20 meet pressure-applying members 18 to form approximately straight angles. It will be understood that jaws 20 may be disposed at any suitable angle with respect to pressure-applying members 18. A sensor 30 on one jaw 20 is also shown, with a portion of cable 32 shown disposed along a portion of a pressure-applying member 18. Tissue-contacting surfaces 22 are shown in FIG. 2 disposed in close apposition to one another. Tissue-contacting surfaces 22 are placed in contact with tissue, including a portion of a blood vessel, disposed between jaws 20. Partial or complete closure of jaws 20 causes tissue-contacting surfaces 22 to apply pressure or force to the tissue effective to compress a blood vessel or the tissue around a blood vessel; the application of pressure or force is effective to compress the tissue and to occlude the blood vessel, reducing or abolishing blood flow through at least a portion of the blood vessel.

A sensor 30 may be effective to detect the location of a blood vessel and to detect blood flow in a blood vessel. Such detection may be used to direct a system 10 so as to ensure that body tissue including a portion of a blood vessel to be occluded is between jaws 20 of the clamping component 12. In preferred methods of use, the blood vessel and surrounding tissue is disposed between jaws 20 and pressure or force is applied to the tissue by tissue-contacting surfaces 22, applying pressure to the tissue, effective to compress a portion of a blood vessel and to at least partially occlude the blood vessel. Such compression and resulting occlusion of a blood vessel is effective to reduce or abolish blood flow in the vessel. Sensor 30, disposed on jaws 20, may be effective to sense the reduction or abolition of blood flow in a compressed blood vessel.

FIG. 3 illustrates in greater detail the distal portion of a system 10 embodying features of the invention, showing a distal portion of a clamping component 12 having pressure-applying members 18 with jaws 20 having tissue-contacting surfaces 22. A sensor 30 is shown disposed on a jaw 20 on the tissue-contacting surface 22, with a distal portion of a cable 32 disposed opposite the tissue-contacting surface 22.

FIG. 4 is a cross-sectional view of a jaw 20, taken through a sensor 30 along line 4-4 of FIG. 3. FIGS. 3 and 4 illustrate tissue contacting jaw 20 has pressure applying surface, that is tissue-contacting surfaces 22 or tissue-contacting teeth 22, a first and a second lateral side walls extending away from the pressure applying surface. The pressure applying surface has a recess formed therein for receiving sensor 30. The sensor 30 is disposed in the recess, bounded by the first and second lateral side walls and lies between the tissue-contacting teeth 22. The blood flow sensor 30 is spaced from the opposing pressure applying surface of the opposing clamping member when said device is in the closed position. The sensor 30 is connected with cable 32 by connection 38, which may be a wire, plurality of wires, optical fiber, waveguide, or other connection effective to carry signals and/or energy or power between a sensor 30, a cable 32, and a sensor controller 36. Preferably, connection 38 is a continuation of at least a portion of cable 32.

A sensor 30 may be a blood flow sensor for locating a blood vessel, and may be a passive sensor, configured to detect intrinsic signals indicating the presence of a blood vessel (i.e., a sound sensor, a motion sensor, a pH sensor, or other sensor configured to detect a physical, chemical, electrical, or physiological indication of the location of a blood vessel). In other embodiments, a blood flow sensor for locating a blood vessel may be an active sensor, configured to emit energy or a signal, and configured to detect signals in response to, or derived from, the emitted energy or signal indicating the presence of a blood vessel (i.e., a source of ultrasound having an ultrasound sensor configured to detect ultrasound reflections from a blood vessel, a source of infrared radiation configured to detect reflections from a blood vessel, or other source of energy and a sensor configured to detect a response indicating the location of a blood vessel). The operation of a sensor may be aided by an energy source (which may be provided by a sensor controller 36), which may directly provide the energy detected by the sensor, or which may aid the sensor to provide the energy to be sensed. For example, an energy source may provide electrical energy which aids an ultrasound sensor to produce and to detect ultrasound energy (as, e.g., in the MedaSonics® CardioBeat® Blood Flow Doppler with Integrated Speaker (Cooper Surgical, Inc., Trumbull Conn. 06611)). Other commercially available Doppler ultrasound sensors suitable for use in the present invention include the Koven model ES 100X MiniDop VRP-8 probe (St. Louis, Mo.) and the DWL/Neuro Scan Medical Systems' Multi-Dop B+system (Sterling, Va.).

Non-invasive blood vessel occluding devices embodying features of the invention include clamping devices having a pressure-applying member configured to apply pressure or force to a blood vessel and a blood flow sensor. A pressure-applying member may have a distal portion configured to engage tissue. Non-invasive blood vessel occluding devices embodying features of the invention may have two, or more, pressure-applying members. Two pressure-applying members maybe disposed opposite each other and configured to move and/or to apply pressure or force towards each other, such as to close together, effective to engage tissue and to clamp a blood vessel between them. Alternatively, a pressure-applying member may have two portions disposed in apposition to one another, effective to clamp tissue between the portions.

Closure of a blood vessel, which may be partial or total, is effected by pressure applied through a body wall, such as the vaginal mucosa. Sufficient pressure or force applied to tissue is effective to apply pressure to that tissue and to underlying tissues and so to compress and to at least partially occlude a blood vessel. An amount of pressure applied through a body wall to effect closure of a blood vessel may be between about 15 pounds per square inch (psi) and about 125 psi, and may preferably be between about 30 psi and about 60 psi. For example, where the pressure-applying surface has a surface area of about 0.16 square inches (e.g., a surface with dimensions of about 0.2 inches by about 0.8 inches), the amount of force applied by a non-invasive artery occluding device embodying features of the invention is preferably between about 3 pounds and about 20 pounds, and more preferably between about 6 pounds and about 9 pounds.

A sensor for detecting or locating a blood vessel may be any sensor configured to detect a blood vessel in place within body tissue. Such a sensor may detect sound, such as heart sounds, or other sounds intrinsically associated with blood vessels. Alternatively, a sensor for locating an artery may produce or be associated with artificially created light or sound, such as ultrasound, and detect reflections or other signals derived from the artificially-produced light or sound. In preferred embodiments, a sensor may be a blood flow sensor. A blood flow sensor, such as a Doppler blood flow sensor, may be disposed perpendicular to the tissue-contacting surface 22 of a jaw 20, effective that only arteries facing a jaw 20, or within the jaws 20, are detected by the blood flow sensor.

A sensor may detect a blood vessel, or blood flow, or signals related to the location of a blood vessel or of blood flow, in a particular direction. For example, a sensor disposed on a tissue-contacting surface of a pressure-applying member, such as a jaw of a clamp, may detect signals from a direction perpendicular to the surface of the jaw, and so be effective to locate blood vessels or detect blood flow opposite the jaw. Such an orientation is effective to insure that a blood vessel to be occluded is positioned opposite a jaw, and between a pair of jaws, and so is properly placed for occlusion. A sensor may also be configured to detect signals from directions parallel to a tissue-contacting surface, or at some other angle with respect to a tissue-contacting surface; such configurations are useful, for example, for directing the movement of a non-invasive artery occluding device towards a blood vessel.

A blood flow sensor preferably includes Doppler ultrasound sensor. A blood flow sensor may be disposed on a clamping member, preferably on a distal portion configured to engage tissue, more preferably near the middle of the distal portion. A blood flow sensor disposed on a pressure-applying member may be configured to detect blood flow in a blood vessel near to the pressure-applying member, and may be configured to detect blood flow in a blood vessel clamped by a pressure-applying member or between pressure-applying members. Non-invasive blood vessel occluding devices embodying features of the invention may include more than one blood flow sensor. Preferred blood flow sensor include Doppler ultrasound blood flow sensors and near infrared blood flow sensors.

A non-invasive blood vessel occluding device embodying features of the invention may be configured to lock into a clamping position. Such a locked configuration may be temporary and releasable, or may be permanent. Non-invasive blood vessel occluding devices embodying features of the invention may have a locking mechanism, such as a ratchet, configured to hold at least one pressure-applying member in a pressure-applying position. Such locking mechanisms may include a release mechanism effective to allow the cessation of pressure or force application when desired. Thus, a non-invasive blood vessel occlusion device embodying features of the invention may be configured to release a locking mechanism effective to relieve the occlusion of a blood vessel by ending the application of pressure or force that had been previously applied to occlude a blood vessel.

The apparatus and systems of the present invention are configured for use within a body cavity and for use adjacent a patient's skin or other body surface, but are non-invasive and configured for external use. Clamping devices may be of any suitable size, which is determined in part by the location and dimension of the artery to be occluded. The handle, jaws, and if present, connecting portion, are configured to allow access to tissue adjacent a blood vessel such as a uterine artery and to provide a clamping pressure or force to the tissue sufficient to occlude the blood vessel to reduce or abolish blood flow in it.

The inventors have discovered that uterine arteries in human females are located adjacent the vaginal mucosa at a location within a few centimeters (cm), or within less than an inch to a few inches, of the vaginal fornix. Thus, for accessing and occluding a uterine artery, the dimensions of a vagina help to determine suitable sizes for clamping devices and clamp applicators embodying features of the invention so that at least a portion of a vaginal clamp is configured to fit within a vagina, and can may readily reach the vaginal fornix when operated from outside of a patient's body. For example, a clamping device may be between about 0.5 inch and about 16 inches in length, preferably between about 1 inch and about 12 inches in length.

Apparatus and systems configured for detecting and occluding blood flow embodying features of the invention are configured to invaginate vaginal mucosa when disposed within a vagina near to a uterine artery. Such apparatus and systems are configured to invaginate vaginal mucosa without puncturing a vaginal wall; that is, without passing through the vaginal mucosa. A sensor may be configured, for example, to detect blood flow in an artery such as a uterine artery without puncturing a patient's skin or mucosal surface. A jaw or jaws of a device and of a system embodying features of the invention may be configured to compress tissue adjacent an artery such as a uterine artery without puncturing a patient's skin or mucosal surface. Thus, a vaginal clamp embodying features of the invention is effective to detect the location of an artery such as a uterine artery and to occlude it.

A vaginal clamp embodying features of the invention may have a jaw or jaws configured to engage a uterine artery or to engage tissue adjacent a uterine artery, and may have an ultrasound sensor, such as a Doppler ultrasound sensor, mounted in a jaw. A Doppler ultrasound sensor operating at ultrasound frequencies less than about 20 MHz, such as between about 5 MHz and about 19 MHz, preferably between about 6 MHz and about 10 MHz, more preferably at about 8 Hz, is suitable for detecting blood flow in an artery with apparatus embodying features of the invention. A sensor is preferably mounted to the face of the clamp jaw and oriented perpendicularly to the jaw face. For example, a blood flow sensor may be mounted between about 0.1″ and about 1″ from the distal tip of a clamp jaw, and is preferably mounted about 0.2 to about 0.6″, more preferably about 0.4″ from the distal tip of a clamp jaw. A clamp jaw may be configured to tightly engage tissue, i.e., may have a surface that is serrated, scored, roughened, coated with a rough material including sandpaper, or otherwise configured to grip tissue. For example, a clamp jaw may be serrated in order to obtain sufficient grip force to remain in position over a uterine artery when clamped onto vaginal mucosa. A non-invasive artery occluding device may have more than two jaws. Multiple jaws are preferably disposed approximately symmetrically about a central axis, and configured so that all jaws approach a central position when closed, so that, for example, three jaws may be oriented approximately 120° from each other and disposed to close to a central point effective to capture tissue between them.

The dimensions of a vaginal clamp embodying features of the invention are chosen to facilitate use within a vagina, and so that the clamp may readily reach the vaginal fornix when operated from outside of a patient's body.

A jaw or jaws may be configured to join with the connecting portion on a line substantially parallel to a line along the connecting portion, or may join at an angle to such a line. An angle between a jaw or jaws and a connecting portion may be acute or may be obtuse. In preferred embodiments, the connection between a jaw or jaws and a connecting portion or portions is a rigid connection; in some embodiments, a jaw may be an extension of a connecting portion, and both may be formed of a single piece of material.

Methods and devices embodying features of the invention may be used to occlude any artery; in the following discussion, the uterine artery is used as an example. It will be understood that the methods and devices discussed in regard to this example may also be applied to any other artery, particularly any other artery located near a body wall such as a vaginal wall, a rectal wall, and abdominal wall, skin surface, or other body surface.

FIG. 5 illustrates a typical human female reproductive system, including a uterus 40, vagina 42, right ovary 44, and left ovary 46. Blood is supplied to the uterus 40 primarily via the right uterine artery 48 and the left uterine artery 50, and secondarily via the right ovarian artery 52 and the left ovarian artery 54, all of which are supplied by the aorta 56. Note the close apposition of the uterine arteries 48 and 50 to the vaginal fornix 58 and to the uterine cervix 60.

A method of occluding an artery includes sensing an artery, and compressing an artery with a clamping device having a blood flow sensor. Sensing an artery may include sensing blood flow, such as blood flow in an artery. Compressing an artery may include grasping tissue near to an artery, and may include compressing tissue surrounding an artery effective to compress the artery.

One method of occluding a uterine artery includes applying an artery occluding device to the artery so that blood flow through the artery is reduced, or is abolished. Such occlusion may be effected by clamping an artery such as a uterine artery. Clamping of a uterine artery may be accomplished by applying a clamping device to tissue near to a uterine artery effective to compress the uterine artery.

FIG. 6 illustrates the use of a non-invasive artery occluding device embodying features of the invention. A vaginal clamp 12 (the clamping component of a non-invasive artery occluding system 10, only parts of which are illustrated in FIG. 6) is shown partially within a vagina 42 of a female patient having a uterus 40 with a uterine fibroid 62 (one of the several medical conditions which may be treated by occlusion of the uterine arteries). The uterine arteries 48 and 50 approach the uterus 40 not far from the vaginal fornix 58 and the uterine cervix 60. The vaginal clamp 12 has handles 14 with finger holes 16, and pressure-applying members 18 with jaws 20 having tissue-contacting surfaces 22. The vaginal clamp 12 also includes a sensor 30 on a jaw 20 facing the patient's tissue, and communicating with other parts of the system 10 (not shown in the Figure) via a cable 32.

A uterine artery may be accessed via the vagina of a patient, and compressing a uterine artery may be accomplished by compressing a portion of the vaginal wall around a portion of a uterine artery. The vaginal clamp is able to access the uterine arteries via the vagina 42, by pressing with jaws 20 on the vaginal wall near the vaginal fornix 58 so as to distend portions 64 and 66 of the vaginal wall to more closely approach the right uterine artery 48. Pressure from jaws 20 is thus effective to invaginate the vaginal wall in order to bring tissue around uterine artery 48 as shown in FIG. 6. Sensor 30 is effective to detect the presence of and to locate uterine artery 48, and to detect blood flow in the artery 48. Sensor 30 may be used to aid in positioning jaws 20 and tissue-contacting surfaces 22 to best surround uterine artery 48 by vaginal wall portions 64 and 66 and associated tissue. Closing jaws 20 presses tissue-contacting surfaces 22 more strongly into the vaginal wall portions 64 and 66, compressing uterine artery 48 and other tissue between the jaws 20, effective to occlude uterine artery 48. Sensor 30 may be used to detect the resulting reduction or abolition of blood flow in uterine artery 48, and to adjust the amount of pressure or force used in order to effect the desired amount of reduction in blood flow and to confirm abolition of blood flow if desired. A locking mechanism 26 may be used to maintain the desired amount of pressure or force on the tissue for a desired amount of time. Blood flow in the left uterine artery 50 may be similarly occluded, by the same vaginal clamp 12 (after release of the occlusion of the right uterine artery 48) or by a different vaginal clamp 12 (thus allowing simultaneous clamping and occlusion of both uterine arteries).

A clamping device suitable for use in a method embodying features of the invention may be a releasable clamping device, so that a uterine artery may remain occluded for only a limited time. A suitable limited time may be between about 0.2 hours and about 12 hours, or preferably between about 0.5 hours and about 4 hours.

Non-invasive artery occluding devices embodying features of the invention may be made from any suitable material or combination of materials, including metals such as stainless steel and shape memory alloys such as nickel titanium alloys, plastics, ceramics, and other materials known in the art. Biocompatible polymers, such as for example, polycarbonate, polysulfone, polyester, polyacetal, and other polymers may be particularly suitable for embodiments of the invention. The device or system may be designed for single use (disposable) or may be sterilizable and capable of multiple use.

While particular forms of the invention have been illustrated and described, it will be apparent that various modifications can be made without departing from the spirit and scope of the invention. Accordingly, it is not intended that the invention be limited to the specific embodiments illustrated. It is therefore intended that this invention be defined by the scope of the appended claims as broadly as the prior art will permit, and in view of the specification if need be. Moreover, those skilled in the art will recognize that features shown in one embodiment may be utilized in other embodiments. Terms such a “element”, “member”, “device”, “sections”, “portion”, “section”, “steps” and words of similar import when used herein shall not be construed as invoking the provisions of 35 U.S.C. §112(6) unless the following claims expressly use the terms “means” or “step” followed by a particular function without specific structure or action.

Claims

1. A device for occluding a uterine artery comprising:

a pair of elongated clamping members that are pivotally connected together, each of said clamping members having a proximal end and a distal end with a tissue contacting jaw, said tissue contacting jaw having a pressure applying surface and first and second lateral side walls extending away from the pressure applying surface, wherein the pressure applying surface of at least one of said clamping members has a recess formed therein; and
a blood flow sensor disposed in the recess of the at least one of said clamping members for locating a uterine artery and monitoring blood flow through the uterine artery, wherein said blood flow sensor is located between and bounded by said first and second lateral side walls of the at least one of said clamping members, wherein the pressure applying surface of the at least one of said clamping members comprises a row of tissue-contacting teeth, and wherein said blood flow sensor lies between said tissue-contacting teeth.

2. The device as claimed in claim 1, wherein said device is moveable between an open position and a closed position, and wherein said blood flow sensor is spaced from the pressure applying surface of an opposing one of said clamping members when said device is in the closed position.

3. The device as claimed in claim 1, wherein said blood flow sensor is selected from the group of sensors consisting of ultrasound sensors, pressure sensors, strain sensors, stress sensors, chemical sensors, electromagnetic radiation sensors, and combinations thereof.

4. The device as claimed in claim 1, wherein said blood flow sensor comprises a Doppler ultrasound sensor.

5. The device as claimed in claim 4, wherein said Doppler ultrasound sensor is configured to sense ultrasound energy having a frequency of between about 5 MHz and about 19 MHz.

6. The device as claimed in claim 4, wherein said Doppler ultrasound sensor is configured to sense ultrasound energy having a frequency of between about 6 MHz and about 10 MHz.

7. The device as claimed in claim 4, wherein said Doppler ultrasound sensor is configured to sense ultrasound energy having a frequency of about 8 MHz.

8. The device as claimed in claim 1, wherein said blood flow sensor is an electromagnetic radiation sensor configured to sense electromagnetic radiation having a wavelength of between about 500 nm and about 2000 nm.

9. The device as claimed in claim 1, wherein said blood flow sensor is an electromagnetic radiation sensor configured to sense electromagnetic radiation having a wavelength of between about 700 nm and about 1000 nm.

10. The device as claimed in claim 1, wherein said blood flow sensor has a sensing direction that is perpendicular to the pressure applying surface.

11. The device as claimed in claim 1, wherein said blood flow sensor is spaced between about 0.1 inch and about 1 inch proximal of the distal end of said clamping member associated therewith.

12. The device as claimed in claim 1, wherein said elongated clamping members have a length of up to about 16 inches.

13. The device as claimed in claim 1, wherein said elongated clamping members have a length up to about 12 inches.

14. The device as claimed in claim 1, wherein the proximal ends of said elongated clamping members are releasably secureable together to retain said tissue contacting jaws in a desired position.

15. The device as claimed in claim 14, wherein the proximal ends of said elongated clamping members have releasable ratchet-type locking mechanisms.

16. The device as claimed in claim 1, wherein at least one blood flow sensor is disposed on each of said tissue contacting jaws.

17. The device as claimed in claim 1, further comprising a blood flow sensor controller in communication with said blood flow sensor, wherein said blood flow sensor controller has a source of electrical power.

18. The device as claimed in claim 17, wherein said blood flow sensor controller comprises a Doppler ultrasound controller.

19. The device as claimed in claim 17, wherein said blood flow sensor controller is adapted to provide an output detectable by an operator.

20. A uterine artery occlusion device, comprising:

a pair of pivotally connected clamping members, each said clamping member having a distal tip configured to invaginate a vaginal wall, a pressure applying surface for applying pressure to vaginal tissue to occlude an underlying uterine artery, first and second lateral side walls extending away from the pressure applying surface, and an elongated handle configured to be operated outside of a vaginal; and
a blood flow sensor on at least one of the pressure applying surfaces of said clamping members proximal to the distal tip thereof for locating the underlying uterine artery, wherein the at least one of the pressure applying surfaces has a recess formed therein and said blood flow sensor is disposed in the recess, wherein said blood flow sensor is located between and bounded by said first and second lateral side walls of the at least one of said clamping members, wherein the pressure applying surface of the at least one of said clamping members comprises a row of tissue-contacting teeth, and wherein said blood flow sensor lies between said tissue-contacting teeth.

21. The device as claimed in claim 20, wherein said blood flow sensor is spaced from the opposing pressure applying surface of said opposing clamping member when said device is in the closed position.

Referenced Cited
U.S. Patent Documents
2400251 May 1946 Nagel
3063455 November 1962 Markley
3209753 October 1965 Hawkins et al.
3411505 November 1968 Nobis
3777740 December 1973 Hokanson
3779248 December 1973 Karman
4120302 October 17, 1978 Ziegler
4192313 March 11, 1980 Ogami
4292960 October 6, 1981 Paglione
4428374 January 31, 1984 Auburn
4428379 January 31, 1984 Robbins et al.
4475544 October 9, 1984 Reis
4509528 April 9, 1985 Sahota
4650466 March 17, 1987 Luther
4757823 July 19, 1988 Hofmeister et al.
4945896 August 7, 1990 Gade
4991588 February 12, 1991 Pflueger et al.
4994069 February 19, 1991 Ritchart et al.
5037430 August 6, 1991 Hasson
5037433 August 6, 1991 Wilk et al.
5081997 January 21, 1992 Bosley, Jr. et al.
5108408 April 28, 1992 Lally
5201314 April 13, 1993 Bosley et al.
5226911 July 13, 1993 Chee et al.
5275166 January 4, 1994 Vaitekunas et al.
5277181 January 11, 1994 Mendelson et al.
5289831 March 1, 1994 Bosley
5336229 August 9, 1994 Noda
5336231 August 9, 1994 Adair
5383922 January 24, 1995 Zipes et al.
5427108 June 27, 1995 Bollinger
5447515 September 5, 1995 Robicsek
5456693 October 10, 1995 Conston et al.
5458596 October 17, 1995 Lax et al.
5488958 February 6, 1996 Topel et al.
5496331 March 5, 1996 Xu et al.
5507744 April 16, 1996 Tay et al.
5520698 May 28, 1996 Koh
5542944 August 6, 1996 Bhatta
5549624 August 27, 1996 Mirigian et al.
5549824 August 27, 1996 Trumpf et al.
5556396 September 17, 1996 Cohen et al.
5562680 October 8, 1996 Hasson
5570692 November 5, 1996 Morinaga
5582617 December 10, 1996 Klieman et al.
5588960 December 31, 1996 Edwards et al.
5591173 January 7, 1997 Schifano
5598841 February 4, 1997 Taniji et al.
5614204 March 25, 1997 Cochrum
5658299 August 19, 1997 Hart
5662676 September 2, 1997 Koninckx
5662680 September 2, 1997 Desai
5665096 September 9, 1997 Yoon
5672153 September 30, 1997 Lax et al.
5672172 September 30, 1997 Zupkas
5691314 November 25, 1997 Hodgen
5697937 December 16, 1997 Toma
5697942 December 16, 1997 Palti
5702407 December 30, 1997 Kaji
5713371 February 3, 1998 Sherman et al.
5713896 February 3, 1998 Nardella
5713942 February 3, 1998 Stern et al.
5715832 February 10, 1998 Koblish et al.
5716389 February 10, 1998 Walinsky et al.
5720743 February 24, 1998 Bischof et al.
5749879 May 12, 1998 Middleman et al.
5759154 June 2, 1998 Hoyns
5766135 June 16, 1998 Terwilliger
5776129 July 7, 1998 Mersch
5792059 August 11, 1998 Furia et al.
5797397 August 25, 1998 Rosenberg
5800378 September 1, 1998 Edwards et al.
5817022 October 6, 1998 Vesely
5836906 November 17, 1998 Edwards
5840033 November 24, 1998 Takeuchi
5895386 April 20, 1999 Odell et al.
5895395 April 20, 1999 Yeung
5899861 May 4, 1999 Friemel et al.
5904651 May 18, 1999 Swanson et al.
5910484 June 8, 1999 Haupert, Jr.
5911691 June 15, 1999 Mochizuki et al.
5916173 June 29, 1999 Kirsner
5921933 July 13, 1999 Sarkis et al.
5941889 August 24, 1999 Cermak
5979453 November 9, 1999 Savage et al.
6013088 January 11, 2000 Karavidas
6015541 January 18, 2000 Greff et al.
6019724 February 1, 2000 Gronningsaeter et al.
6032673 March 7, 2000 Savage et al.
6033398 March 7, 2000 Farley et al.
6034477 March 7, 2000 Peeters et al.
6035238 March 7, 2000 Ingle et al.
6045508 April 4, 2000 Hossack et al.
6066139 May 23, 2000 Ryan et al.
6077257 June 20, 2000 Edwards et al.
6080118 June 27, 2000 Blythe
6096051 August 1, 2000 Kortenbach et al.
6106473 August 22, 2000 Violante et al.
6152874 November 28, 2000 Looney et al.
6169914 January 2, 2001 Hovland et al.
6175751 January 16, 2001 Maizes
6210330 April 3, 2001 Tepper
6231515 May 15, 2001 Moore et al.
6254601 July 3, 2001 Burbank et al.
6261234 July 17, 2001 Lin
6280441 August 28, 2001 Ryan
6293954 September 25, 2001 Fogarty et al.
6299621 October 9, 2001 Fogarty et al.
6368340 April 9, 2002 Malecki et al.
6371973 April 16, 2002 Tepper
6425867 July 30, 2002 Vaezy et al.
6602251 August 5, 2003 Burbank et al.
6610074 August 26, 2003 Santilli
6635017 October 21, 2003 Moehring et al.
6905506 June 14, 2005 Burbank et al.
20020111537 August 15, 2002 Taylor et al.
20020165579 November 7, 2002 Burbank et al.
20020183771 December 5, 2002 Burbank et al.
20020188306 December 12, 2002 Burbank et al.
20030018270 January 23, 2003 Makin et al.
20030120306 June 26, 2003 Burbank et al.
20040097962 May 20, 2004 Burbank et al.
20040153097 August 5, 2004 Burbank et al.
20050113634 May 26, 2005 Burbank et al.
20050113852 May 26, 2005 Burbank et al.
Foreign Patent Documents
195 28 440 February 1997 DE
200 22 012 May 2001 DE
0 472 368 February 1992 EP
0 598 579 May 1994 EP
0 890 342 January 1999 EP
1 072 282 January 2001 EP
1 220 773 May 1960 FR
2 302 025 January 1997 GB
2 311 468 January 1997 GB
63-46105 March 1988 JP
1159821 November 1989 JP
7-008493 January 1995 JP
WO 95/02370 January 1995 WO
WO 95/02371 January 1995 WO
WO 96/10365 April 1996 WO
WO 97/27897 August 1997 WO
WO 97/47246 December 1997 WO
WO 98/19713 May 1998 WO
WO 98/38486 September 1998 WO
WO 99/00057 January 1999 WO
WO 99/11179 March 1999 WO
WO 99/11179 March 1999 WO
WO 00/33724 June 2000 WO
WO 01/80713 November 2001 WO
WO 02/39904 May 2002 WO
WO 02/078521 October 2002 WO
WO 02/078522 October 2002 WO
WO 02/078549 October 2002 WO
WO 2004/045420 June 2004 WO
WO 2004/045426 June 2004 WO
WO 2004/071275 August 2004 WO
Other references
  • International Search Report for PCT/US03/36553 mailed Apr. 1, 2004.
  • International Search Report for PCT/US03/35815 mailed Jun. 30, 2004.
  • International Search Report for PCT/US04/03023 mailed Feb. 9, 2005.
  • International Search Report for PCT/US04/01935 mailed Feb. 15, 2005.
  • International Preliminary Report of Patentability for Serial No. PCT/US04/01935, mailed Jul. 8, 2005.
  • International Search Report for PCT/US2006/031226 mailed Dec. 6, 2006.
  • Written Opinion of the International Searching Authority for PCT/US2006/031226 mailed Dec. 6, 2006.
  • Barth, Klemens H. et al., “Long Term Follow-Up of Transcatheter Embolization With Autologous Clot, Oxycel and Gelfoam in Domestic Swine”, Investigative Radiology, May-Jun. 1977, vol. 12, pp. 273-290.
  • Bateman, William M.D., “Treatment of intractable menorrhagia by bilateral uterine vessel, Interruption”, Am. J. Obst. & Gynec. 89(6):825-827 (Jul. 15, 1964).
  • Brigato, G. et al., “A Noninvasive Instrumental Method in Severe Postpartum Hemorrhages”, Minerva Ginecologica 50(7-8):337-339 (1998).
  • Brohim, Robert M. et al., “Development of Independent Vessel Security After Ligation With Absorbable Sutures or Clips”, The American Journal of Surgery, Mar. 1993, vol, 165, pp. 345-348.
  • Burbank, Fred et al., “Uterine Artery Occlusion by Embolization or Surgery for the Treatment of Fibroids: A Unifying Hypothesis-Transient Uterine lschemia”, The Journal of the American Association of Gynecologic Laparoscopists, Nov. 2000, vol. 7, No. 7 Supplemental, pp. S3-S49.
  • Fuchs, Karl, “Afibrinogenemia Treated by Ligation of Uterine Arteries”, Gynacologic 148:407-411 (1959).
  • Garza Leal, J. et al., “Myoma Treatment by Transient Uterine lschemia”, The Journal of the American Association of Gynecologic Laparoscopists 7(3):S31 (Aug. 2000).
  • Hay, D.L. et al., “Hemostasis in Blood Vessels After Ligation”, Am, J. Obstet. Gynecol., Mar. 1989, 160:3, pp. 737-739.
  • Hunerbein, M. et al., “Endoscopic Ultrasound-Guided Real Time Biopsy of Peri-Intestinal Tumors”, Surgical Technology International VII, 1998, pp. 91-95.
  • O'Leary, James A., M.D., “Uterine Artery Ligation in the Control of Postcesarean Hemorrhage”, The Journal of Reproductive Medicine, Inc., 40(3):189-193 (Mar. 1995).
  • O'Leary, James L., M.D. et al., “Uterine artery ligation in the control of intractable postpartum hemorrhage”, Am. J. Obst. & Gynec. 94(7):920-924 (Apr. 1, 1966).
  • Ravina, J.H. et al., “Arterial Embolisation to Treat Uterine Myomata”, The Lancet, Sep. 9, 1995, vol. 346, No. 8976, pp. 671-672.
  • Schaefer, C.J. et al., “Absorbable Ligating Clips”, Surg. Gynecol. Obstet., 1982, 154:513-516.
  • “Mick 200-TP Applicator Package”, Mick Radio-Nuclear Instruments, Inc., advertisement, 2000.
  • “Multiplanar Biopsy Transverse Scan”, Bruel & Kjaer Medical Systems, Inc., advertisement, 2000.
  • “Seeding Device—P roscan Urologic Ultrasound Imaging System”, Teknar, advertisement, 2000.
  • Sonopsy Ultrasound Guided Breast Biopsy, NeoVision, advertisement, 2000.
  • “Transrectal Biopsy of the Prostrate Gland”, Bruel & Kjaer Medical Systems, Inc., advertisement, 2000.
  • International Search Report for PCT/US02/09745 mailed Sep. 12, 2002.
  • International Search Report for PCT/US02/23347 mailed Nov. 20, 2002.
  • International Search Report for PCT/US02/22015 mailed Dec. 3, 2002.
  • International Search Report for EP 99 96 7154 (PCT/US99/28101) mailed Dec. 3, 2002.
  • International Preliminary Report on Patentability and Written Opinion of the International Searching Authority for International Application No. PCT/US2006/031226, mailed Mar. 13, 2008.
  • International Search Report for PCT/US2004/038276, mailed Mar. 15, 2005.
  • International Search Report for PCT/US2004/038111, mailed May 3, 2005.
  • Written Opinion for PCT/US2004/038111, mailed May 3, 2005.
  • Translation of FR 1 220 773, May 1960.
Patent History
Patent number: 8052718
Type: Grant
Filed: Nov 19, 2002
Date of Patent: Nov 8, 2011
Patent Publication Number: 20030120306
Assignee: Vascular Control Systems, Inc. (San Juan Capistrano, CA)
Inventors: Fred H. Burbank (Laguna Niguel, CA), Michael L. Jones (San Clemente, CA), R. J. Serra (Irvine, CA), Greig E. Altieri (Laguna Beach, CA), Jill Uyeno (Mission Viejo, CA), Yu-Tung Wong (Irvine, CA), Randy Werneth (Poway, CA)
Primary Examiner: Tuan Nguyen
Application Number: 10/300,115
Classifications
Current U.S. Class: Forceps (606/205)
International Classification: A61B 17/00 (20060101);